Journal - Current Medicinal Chemistry - Anti-Cancer Agents

Impact Factor

Current: 2.469
5 - Year: 2.974

Ranking & Category

29th of 59 in Chemistry, Medicinal

Topic(s) Covered

2 Topic(s)

View

Covered Disease(s)

0 Disease(s)

Aims & Scope

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.

Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication.

Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.

Abstracted/Indexed in

Science Citation Index-Expanded (SciSearch®), Journal Citation Reports/Science Edition, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/PubMed/Index Medicus, Scopus, EMBASE/Excerpta Medica, Chemical Abstracts, ProQuest, BIOBASE, MediaFinder®-Standard Periodical Directory, Genamics JournalSeek, PubsHub, J-Gate and Dimensions.

Journal History

Current Medicinal Chemistry - Anti-Cancer Agents was launched in 2001 and later renamed in 2006 as Anti-Cancer Agents in Medicinal Chemistry.

Announcements

Highlighted Article(s)

Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells, 2014 : 14 (10); 1315 - 1323
Tania Bour, Xianwen Yang, Weihong Li, Francois Bernardin, Tony Kaoma, Arnaud Muller, Laurent Vallar and Andre Steinmetz
DOI: 10.2174/1871520614666140624110458

View Abstract Rights and Permissions

Endorsement(s)

"All chemists and scientists will welcome Anti-Cancer Agents in Medicinal Chemistry as a fresh and vital source of information for this important field. The journal is highly recommended for essential reading."

Terrence C. Jenkins
YCR Laboratory of Drug Design, UK

Authors' Comments

I am glad to have my work published in Anti- Cancer Agents in Cancer. I found the publication process to be professional and efficient. The papers are reviewed rapidly and included promptly to Pubmed. I highly recommend scientists to submit their papers at Bentham Science Publishers.

Dr. Juan Rafael Orozco Arroyave
(Electronic Engineering Department, Universidad de Antioquia, GITA Research Group, Colombia)

Has contributed: FAK and Nanog Cross Talk with p53 in Cancer Stem Cells